CRISPR THERAPEUTICS AG Basic Shares Outstanding (Weighted Average)
CRISPR THERAPEUTICS AG (CRSP) reported Basic Shares Outstanding (Weighted Average) of 96.51 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-03
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 96.51M shares, a 10.85% increase year-over-year.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 96.05M shares, a 11.77% increase year-over-year.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 95.33M shares, a 11.53% increase year-over-year.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 91.31M shares, a 7.12% increase year-over-year.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic for fiscal 2025 was 89.93M shares, a 6.60% increase from fiscal 2024.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic for fiscal 2024 was 84.36M shares, a 6.49% increase from fiscal 2023.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic for fiscal 2023 was 79.22M shares, a 1.90% increase from fiscal 2022.
- CRISPR THERAPEUTICS AG weighted average number of shares outstanding, basic for fiscal 2022 was 77.75M shares, a 2.37% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 96.51M shares 10-Q · filed 2026-08-03 | 96.28M shares 10-Q · filed 2026-08-03 | 95.96M shares derived: average of 3 quarters · filed 2026-08-03 | 94.80M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 96.05M shares 10-Q · filed 2026-05-04 | 95.69M shares derived: average of 2 quarters · filed 2026-05-04 | 94.23M shares derived: average of 3 quarters · filed 2026-05-04 | 92.44M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | 95.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 93.32M shares derived: average of 2 quarters · filed 2026-02-12 | 91.23M shares derived: average of 3 quarters · filed 2026-08-03 | 89.93M shares 10-K · filed 2026-02-12 |
| 2025-09-30 | 91.31M shares 10-Q · filed 2025-11-10 | 89.19M shares derived: average of 2 quarters · filed 2026-08-03 | 88.12M shares 10-Q · filed 2025-11-10 | 87.45M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | 87.07M shares 10-Q · filed 2026-08-03 | 86.51M shares 10-Q · filed 2026-08-03 | 86.16M shares derived: average of 3 quarters · filed 2026-08-03 | 85.93M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | 85.94M shares 10-Q · filed 2026-05-04 | 85.71M shares derived: average of 2 quarters · filed 2026-05-04 | 85.55M shares derived: average of 3 quarters · filed 2026-05-04 | 85.39M shares derived: average of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | 85.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 85.35M shares derived: average of 2 quarters · filed 2026-02-12 | 85.21M shares derived: average of 3 quarters · filed 2026-02-12 | 84.36M shares 10-K · filed 2026-02-12 |
| 2024-09-30 | 85.23M shares 10-Q · filed 2025-11-10 | 85.08M shares derived: average of 2 quarters · filed 2025-11-10 | 83.99M shares 10-Q · filed 2025-11-10 | 82.91M shares derived: average of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | 84.92M shares 10-Q · filed 2025-08-04 | 83.36M shares 10-Q · filed 2025-08-04 | 82.14M shares derived: average of 3 quarters · filed 2026-02-12 | 81.46M shares derived: average of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | 81.79M shares 10-Q · filed 2025-05-06 | 80.74M shares derived: average of 2 quarters · filed 2026-02-12 | 80.30M shares derived: average of 3 quarters · filed 2026-02-12 | 80.00M shares derived: average of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | 79.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 79.55M shares derived: average of 2 quarters · filed 2026-02-12 | 79.40M shares derived: average of 3 quarters · filed 2026-02-12 | 79.22M shares 10-K · filed 2026-02-12 |
| 2023-09-30 | 79.41M shares 10-Q · filed 2024-11-05 | 79.25M shares derived: average of 2 quarters · filed 2024-11-05 | 79.06M shares 10-Q · filed 2024-11-05 | 78.88M shares derived: average of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | 79.09M shares 10-Q · filed 2024-08-05 | 78.89M shares 10-Q · filed 2024-08-05 | 78.70M shares derived: average of 3 quarters · filed 2025-02-11 | 78.53M shares derived: average of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | 78.68M shares 10-Q · filed 2024-05-08 | 78.51M shares derived: average of 2 quarters · filed 2025-02-11 | 78.35M shares derived: average of 3 quarters · filed 2025-02-11 | 78.14M shares derived: average of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | 78.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | 78.18M shares derived: average of 2 quarters · filed 2025-02-11 | 77.96M shares derived: average of 3 quarters · filed 2025-02-11 | 77.75M shares 10-K · filed 2025-02-11 |
| 2022-09-30 | 78.02M shares 10-Q · filed 2023-11-06 | 77.77M shares derived: average of 2 quarters · filed 2023-11-06 | 77.55M shares 10-Q · filed 2023-11-06 | 77.32M shares derived: average of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | 77.51M shares 10-Q · filed 2023-08-07 | 77.31M shares 10-Q · filed 2023-08-07 | 77.09M shares derived: average of 3 quarters · filed 2024-02-21 | 76.89M shares derived: average of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | 77.10M shares 10-Q · filed 2023-05-08 | 76.88M shares derived: average of 2 quarters · filed 2024-02-21 | 76.68M shares derived: average of 3 quarters · filed 2024-02-21 | 76.47M shares derived: average of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | 76.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | 76.47M shares derived: average of 2 quarters · filed 2024-02-21 | 76.26M shares derived: average of 3 quarters · filed 2024-02-21 | 75.95M shares 10-K · filed 2024-02-21 |
| 2021-09-30 | 76.29M shares 10-Q · filed 2022-11-01 | 76.06M shares derived: average of 2 quarters · filed 2022-11-01 | 75.71M shares 10-Q · filed 2022-11-01 | 74.60M shares derived: average of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | 75.83M shares 10-Q · filed 2022-08-08 | 75.42M shares 10-Q · filed 2022-08-08 | 74.04M shares derived: average of 3 quarters · filed 2022-08-08 | 73.06M shares derived: average of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | 75.01M shares 10-Q · filed 2022-05-09 | 73.14M shares derived: average of 2 quarters · filed 2022-05-09 | 72.14M shares derived: average of 3 quarters · filed 2022-05-09 | 69.46M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 71.28M shares 10-K · filed 2021-02-16 | 70.71M shares derived: average of 2 quarters · filed 2021-11-03 | 67.62M shares derived: average of 3 quarters · filed 2021-11-03 | 65.95M shares 10-K · filed 2023-02-21 |
| 2020-09-30 | 70.14M shares 10-Q · filed 2021-11-03 | 65.78M shares derived: average of 2 quarters · filed 2021-11-03 | 64.16M shares 10-Q · filed 2021-11-03 | 62.45M shares derived: average of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | 61.42M shares 10-Q · filed 2021-07-29 | 61.13M shares 10-Q · filed 2021-07-29 | 59.89M shares derived: average of 3 quarters · filed 2021-07-29 | 58.62M shares derived: average of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | 60.85M shares 10-Q · filed 2021-04-27 | 59.12M shares derived: average of 2 quarters · filed 2021-04-27 | 57.69M shares derived: average of 3 quarters · filed 2021-04-27 | 56.57M shares derived: average of 4 quarters · filed 2021-04-27 |
| 2019-12-31 | 57.40M shares 10-K · filed 2021-02-16 | 56.11M shares derived: average of 2 quarters · filed 2021-02-16 | 55.14M shares derived: average of 3 quarters · filed 2021-02-16 | 54.39M shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 54.83M shares 10-K · filed 2021-02-16 | 54.01M shares derived: average of 2 quarters · filed 2021-02-16 | 53.38M shares 10-Q · filed 2020-10-28 | 52.95M shares derived: average of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | 53.19M shares 10-K · filed 2021-02-16 | 52.64M shares derived: average of 2 quarters · filed 2021-02-16 | 52.32M shares derived: average of 3 quarters · filed 2021-02-16 | 51.09M shares derived: average of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | 52.09M shares 10-K · filed 2021-02-16 | 51.89M shares derived: average of 2 quarters · filed 2021-02-16 | 50.39M shares derived: average of 3 quarters · filed 2021-02-16 | 49.50M shares derived: average of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | 51.69M shares 10-K · filed 2020-02-12 | 49.54M shares derived: average of 2 quarters · filed 2020-02-12 | 48.64M shares derived: average of 3 quarters · filed 2020-02-12 | 47.96M shares 10-K · filed 2021-02-16 |
| 2018-09-30 | 47.39M shares 10-K · filed 2020-02-12 | 47.12M shares derived: average of 2 quarters · filed 2020-02-12 | 46.71M shares 10-Q · filed 2019-10-28 | 45.16M shares derived: average of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | 46.84M shares 10-K · filed 2020-02-12 | 46.36M shares derived: average of 2 quarters · filed 2020-02-12 | 44.41M shares derived: average of 3 quarters · filed 2020-02-12 | 43.33M shares derived: average of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | 45.88M shares 10-K · filed 2020-02-12 | 43.19M shares derived: average of 2 quarters · filed 2020-02-12 | 42.16M shares derived: average of 3 quarters · filed 2020-02-12 | 41.59M shares derived: average of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | 40.51M shares 10-K · filed 2019-02-25 | 40.30M shares derived: average of 2 quarters · filed 2019-02-25 | 40.16M shares derived: average of 3 quarters · filed 2019-02-25 | 40.06M shares 10-K · filed 2020-02-12 |
| 2017-09-30 | 40.09M shares 10-K · filed 2019-02-25 | 39.99M shares derived: average of 2 quarters · filed 2019-02-25 | 39.90M shares derived: average of 3 quarters · filed 2019-02-25 | 38.17M shares derived: average of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | 39.90M shares 10-K · filed 2019-02-25 | 39.81M shares derived: average of 2 quarters · filed 2019-02-25 | 37.54M shares derived: average of 3 quarters · filed 2019-02-25 | 29.48M shares derived: average of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | 39.73M shares 10-K · filed 2019-02-25 | 36.36M shares derived: average of 2 quarters · filed 2019-02-25 | 26.00M shares derived: average of 3 quarters · filed 2019-02-25 | 20.86M shares derived: average of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | 32.99M shares 10-K · filed 2018-03-08 | 19.14M shares derived: average of 2 quarters · filed 2018-03-08 | 14.58M shares derived: average of 3 quarters · filed 2018-03-08 | 12.31M shares derived: average of 4 quarters · filed 2018-03-08 |
| 2016-09-30 | 5.29M shares 10-K · filed 2018-03-08 | 5.37M shares derived: average of 2 quarters · filed 2018-03-08 | 5.42M shares derived: average of 3 quarters · filed 2018-03-08 | |
| 2016-06-30 | 5.45M shares 10-K · filed 2018-03-08 | 5.49M shares derived: average of 2 quarters · filed 2018-03-08 | ||
| 2016-03-31 | 5.53M shares 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |